Regencell Bioscience Holdings Limited
RGC
$0.22
Change (1 day)
$32.44
Year High
$3.03
Year Low
Categories
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Revenue of Regencell Bioscience Holdings Limited (RGC)
Revenue in 2024 (TTM): $
According to Regencell Bioscience Holdings Limited's latest financial reports the company's current revenue (TTM) is $. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Regencell Bioscience Holdings Limited
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2024 | $ | $-745,588 | $-3,617,628 | $-4,363,221 | $-4,301,837 |
| 2023 | $ | $-769,687 | $-5,292,644 | $-6,062,329 | $-5,871,130 |
| 2022 | $ | $-604,397 | $-6,990,153 | $-7,594,555 | $-7,422,728 |
| 2021 | $ | $-26,456 | $-1,354,906 | $-1,346,745 | $-1,346,745 |
| 2020 | $ | $-9,516 | $-802,855 | $-812,371 | $-812,371 |
| 2019 | $ | $ | $-390,990 | $-390,990 | $-390,990 |
| 2018 | $3.16 B | $3.04 B | $468.7 M | $213.9 M | $112.3 M |
| 2017 | $3.2 B | $1.97 B | $512.3 M | $281.7 M | $170.4 M |
| 2016 | $3.13 B | $1.92 B | $470.3 M | $253.3 M | $153.4 M |
| 2015 | $2.99 B | $2.88 B | $391 M | $178.6 M | $105.6 M |
| 2013 | $3.04 B | $2.93 B | $469.2 M | $264.6 M | $157.7 M |
| 2012 | $2.82 B | $2.72 B | $422.2 M | $235.9 M | $144.8 M |
| 2011 | $2.81 B | $2.71 B | $352.5 M | $75.7 M | $77.6 M |
| 2010 | $2.89 B | $1.74 B | $512.1 M | $157.2 M | $95.5 M |
| 2009 | $2.77 B | $2.67 B | $200 M | $123 M | $72 M |
| 2007 | $2.66 B | $2.56 B | $676 M | $605 M | $363 M |
| 2006 | $2.6 B | $2.49 B | $215 M | $144 M | $86 M |
| 2005 | $2.47 B | $2.37 B | $220 M | $142 M | $82 M |
| 2004 | $2.49 B | $2.4 B | $392 M | $306 M | $185 M |
| 2002 | $2.14 B | $2.06 B | $401 M | $208 M | $117 M |